Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
dc.contributor.author | Celen, Mustafa Kemal | |
dc.contributor.author | Akdemir, Irem | |
dc.contributor.author | Tekin, Recep | |
dc.contributor.author | Bayan, Kadim | |
dc.contributor.author | Ayaz, Celal | |
dc.date.accessioned | 2024-04-24T17:24:32Z | |
dc.date.available | 2024-04-24T17:24:32Z | |
dc.date.issued | 2017 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recent one is elbasvir/grazoprevir option. This study presents the results of two treatment-naive patients treated with elbasvir/grazoprevir. The first case was a male non-cirrhotic patient and the second one was a female who suffered from compensated hepatic cirrhosis. Both patients received elbasvir/grazoprevir 50/100 mg in a single tablet for 12 weeks. Persistent viral response was achieved in both patients and no side effect was observed during the treatment. Elbasvir/grazoprevir combination, one of the recent treatments, was considered effective and tolerable. | en_US |
dc.identifier.doi | 10.4274/vhd.10337 | |
dc.identifier.endpage | 36 | en_US |
dc.identifier.issn | 1307-9441 | |
dc.identifier.issn | 2147-2939 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 34 | en_US |
dc.identifier.uri | https://doi.org/10.4274/vhd.10337 | |
dc.identifier.uri | https://hdl.handle.net/11468/19722 | |
dc.identifier.volume | 23 | en_US |
dc.identifier.wos | WOS:000404629300009 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | en_US |
dc.publisher | Galenos Yayincilik | en_US |
dc.relation.ispartof | Viral Hepatit Dergisi-Viral Hepatitis Journal | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hepatitis C Virus | en_US |
dc.subject | Oral Antiviral Treatment | en_US |
dc.subject | Elbasvir/Grazoprevir | en_US |
dc.title | Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report | en_US |
dc.title | Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report | |
dc.type | Article | en_US |